These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 18033605

  • 1. Serial injection of botulinum toxin for muscle imbalance due to regional spasticity in the upper limb.
    Turner-Stokes L, Ashford S.
    Disabil Rehabil; 2007 Dec 15; 29(23):1806-12. PubMed ID: 18033605
    [Abstract] [Full Text] [Related]

  • 2. Management of shoulder and proximal upper limb spasticity using botulinum toxin and concurrent therapy interventions: a preliminary analysis of goals and outcomes.
    Ashford S, Turner-Stokes L.
    Disabil Rehabil; 2009 Dec 15; 31(3):220-6. PubMed ID: 18608366
    [Abstract] [Full Text] [Related]

  • 3. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J, Entner T.
    Wien Klin Wochenschr; 2001 Dec 15; 113 Suppl 4():20-4. PubMed ID: 15506048
    [Abstract] [Full Text] [Related]

  • 4. [Botulinum toxin type A treatment of upper limb spasticity].
    Wissel M, Wissel J.
    Wien Klin Wochenschr; 2001 Dec 15; 113 Suppl 4():16-9. PubMed ID: 15506047
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of focal upper limb spasticity with botulinum toxin after stroke. Interest of an individual approach].
    Luauté J, Landrault E, Jacquin-Courtois S, Mertens P, Rode G, Boisson D.
    Ann Readapt Med Phys; 2004 Oct 15; 47(8):555-62. PubMed ID: 15465160
    [Abstract] [Full Text] [Related]

  • 6. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
    Slawek J, Bogucki A, Reclawowicz D.
    Neurol Sci; 2005 Apr 15; 26(1):32-9. PubMed ID: 15877185
    [Abstract] [Full Text] [Related]

  • 7. Management of spasticity and dystonia in children with acquired brain injury with rehabilitation and botulinum toxin A.
    Guettard E, Roze E, Abada G, Lemesle C, Vidailhet M, Laurent-Vannier A, Chevignard MP.
    Dev Neurorehabil; 2009 Jun 15; 12(3):128-38. PubMed ID: 19466620
    [Abstract] [Full Text] [Related]

  • 8. Comparative impact of 2 botulinum toxin injection techniques for elbow flexor hypertonia.
    Mayer NH, Whyte J, Wannstedt G, Ellis CA.
    Arch Phys Med Rehabil; 2008 May 15; 89(5):982-7. PubMed ID: 18452749
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of spasticity in cerebral palsy with botulinum toxin].
    Calderón-González R, Calderón-Sepúlveda RF.
    Rev Neurol; 2008 May 15; 34(1):52-9. PubMed ID: 11988892
    [Abstract] [Full Text] [Related]

  • 10. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
    Kaishou Xu, Tiebin Yan, Jianning Mai.
    Clin Rehabil; 2009 Sep 15; 23(9):800-11. PubMed ID: 19482892
    [Abstract] [Full Text] [Related]

  • 11. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
    Elovic EP, Brashear A, Kaelin D, Liu J, Millis SR, Barron R, Turkel C.
    Arch Phys Med Rehabil; 2008 May 15; 89(5):799-806. PubMed ID: 18452724
    [Abstract] [Full Text] [Related]

  • 12. Botulinum toxin A in the management of focal muscle overactivity in children with cerebral palsy.
    Gibson N, Graham HK, Love S.
    Disabil Rehabil; 2007 Dec 15; 29(23):1813-22. PubMed ID: 18033606
    [Abstract] [Full Text] [Related]

  • 13. The lowest effective dose of botulinum A toxin in adult patients with upper limb spasticity.
    Suputtitada A, Suwanwela NC.
    Disabil Rehabil; 2005 Feb 18; 27(4):176-84. PubMed ID: 15824048
    [Abstract] [Full Text] [Related]

  • 14. Botulinum treatment for post-stroke spasticity: low dose regime.
    Viriyavejakul A, Vachalathiti R, Poungvarin N.
    J Med Assoc Thai; 1998 Jun 18; 81(6):413-22. PubMed ID: 9676073
    [Abstract] [Full Text] [Related]

  • 15. Upper limb function after botulinum toxin A treatment in cerebral palsy: two years follow-up of six cases.
    Sätilä H, Kotamäki A, Koivikko M, Autti-Rämö I.
    Pediatr Rehabil; 2006 Jun 18; 9(3):247-58. PubMed ID: 17050402
    [Abstract] [Full Text] [Related]

  • 16. [Botulinum toxin type A in the treatment plan for cerebral palsy].
    Strobl W.
    Wien Klin Wochenschr; 2001 Jun 18; 113 Suppl 4():30-5. PubMed ID: 15506050
    [Abstract] [Full Text] [Related]

  • 17. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial.
    Rameckers EA, Speth LA, Duysens J, Vles JS, Smits-Engelsman BC.
    Neurorehabil Neural Repair; 2009 Jun 18; 23(3):218-25. PubMed ID: 19106252
    [Abstract] [Full Text] [Related]

  • 18. [Measuring outcome in spasticity rehabilitation].
    Fheodoroff K, Wissel J, Entner T, Freimüller M.
    Wien Klin Wochenschr; 2001 Jun 18; 113 Suppl 4():11-5. PubMed ID: 15506046
    [Abstract] [Full Text] [Related]

  • 19. Botulinum A toxin for treatment of lower limb spasticity in cerebral palsy: gait analysis in 49 patients.
    Papadonikolakis AS, Vekris MD, Korompilias AV, Kostas JP, Ristanis SE, Soucacos PN.
    Acta Orthop Scand; 2003 Dec 18; 74(6):749-55. PubMed ID: 14763710
    [Abstract] [Full Text] [Related]

  • 20. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
    Crowner BE, Racette BA.
    Pediatr Neurol; 2008 Oct 18; 39(4):253-8. PubMed ID: 18805363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.